Satellos Bioscience Files 6-K Report
Ticker: MSLE · Form: 6-K · Filed: 2026-04-09T07:00:08-04:00
Sentiment: neutral
Topics: disclosure, foreign-issuer, regulatory
TL;DR
Satellos Bioscience filed a 6-K on 4/9/26, check press release for details.
AI Summary
Satellos Bioscience Inc. filed a Form 6-K on April 9, 2026, reporting information as a foreign issuer. The filing includes a press release as an exhibit, but no specific financial figures or operational updates are detailed in the provided metadata.
Why It Matters
This filing indicates Satellos Bioscience Inc. is providing updated information to the SEC, which could be relevant for investors monitoring the company's regulatory compliance and disclosures.
Risk Assessment
Risk Level: low — The filing is a routine disclosure report (6-K) with no immediate indication of significant financial or operational changes.
Key Players & Entities
- Satellos Bioscience Inc. (company) — Filer
- 0001421642 (company) — CIK Number
- 2026-04-09 (date) — Filing Date
- 2834 (company) — SIC Code
FAQ
What type of SEC filing is this?
This is a Form 6-K, which is a report of a foreign issuer.
When was this filing accepted by the SEC?
The filing was accepted on 2026-04-09 at 07:00:08.
What is the CIK number for Satellos Bioscience Inc.?
The CIK number for Satellos Bioscience Inc. is 0001421642.
What is the SIC code listed for Satellos Bioscience Inc.?
The SIC code listed is 2834, which corresponds to Pharmaceutical Preparations.
What documents are included in this filing?
The filing includes a Form 6-K document and a press release (EX-99.1).
From the Filing
EDGAR Filing Documents for 0001171843-26-002337 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001171843-26-002337 Filing Date 2026-04-09 Accepted 2026-04-09 07:00:08 Documents 2 Period of Report 2026-04-09 Document Format Files Seq Description Document Type Size 1 FORM 6-K f6k_040826.htm 6-K 6103 2 PRESS RELEASE exh_991.htm EX-99.1 3658 Complete submission text file 0001171843-26-002337.txt 10935 Mailing Address ROYAL BANK PLAZA, S. TOWER, 200 BAY ST. SUITE 2800 TORONTO A6 M5J 2J1 Business Address ROYAL BANK PLAZA, S. TOWER, 200 BAY ST. SUITE 2800 TORONTO A6 M5J 2J1 416-708-0522 Satellos Bioscience Inc. (Filer) CIK : 0001421642 (see all company filings) EIN. : 000000000 | State of Incorp.: Z4 Type: 6-K | Act: 34 | File No.: 001-43107 | Film No.: 26849782 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)